Topics/Speaker:
The Fundamentals
Spinal Cord Stimulation – Mechanism of Action – Ricardo Vallejo, MD, PhD
Evaluation and Treatment of Neck and Arm Pain – Following Cervical Fusion – Thomas Mroz, MD
Sacroiliac Joint RFA: Indications, Better Technique, Better Outcomes? – David “DJ” Kennedy, MD
Cervical Spine Surgery: Watchful Waiting vs. Decompression – Thomas Mroz, MD
New Algorithm for Treatment of Chronic Abdominal Pain – Leo Kapural, MD, PhD
Core Stability – David “DJ” Kennedy, MD
Panel Discussion/Question and Answer
Regulatory, Billing and Ethical Challenges in Pain Practice
Neuromodulation – Will Overuse Kill the Technology? – Timothy R. Deer, MD
Effective Payer Negotiations – Damean Freas, DO
CPT and RUC: How is a Code Created and Get Value? – Richard W. Rosenquist, MD
Effective Billing for Neuromodulation Procedures – Robert Bolash, MD
Medical and Ethical Concerns in Billing – Damean Freas, DO
Emerging Pharmacological and Interventional Treatment
Basivertebral Nerve Ablation for Chronic Vertebrogenic Back Pain – David “DJ” Kennedy, MD
The ReActiv8 Trial – Christopher J. Gilligan, MD
CGRP Antagonists – MaryAnn Mays, MD
Nerve Growth Factor – Mark S. Wallace, MD
Nav1.7 as a Pharmacogenomic Target for Pain – Robert Bolash, MD
Neuromodulation: Effective Utilization of Targets, Techniques, and Devices
Neurostimulation: From Inception to the Future – Nagy Mekhail, MD, PhD
Tonic Stimulation – Ricardo Vallejo, MD, PhD
Burst Stimulation – Timothy R. Deer, MD
High Frequency Stimulation – Leo Kapural, MD, PhD
Feedback Modified Stimulation – Nagy Mekhail, MD, PhD
Intrathecal Drug Delivery – Robert Bolash, MD
Dorsal Root Ganglion Stimulation – Timothy R. Deer, MD
Neuromodulation – Changing Paradigms and Devices: How Do I Choose the Best One for My Patient?
Matching the Diagnosis and the Technique/Device for the Best Patient Outcome – A Case Discussion with the Experts – Nagy Mekhail, MD, PhD
Panel Discussion/Question and Answer
The Opioid Crisis
Buprenorphine: A Viable Alternative? – Robert Bolash, MD
Pharmacogenomics: Fad or the Future? – Jennifer Hockings, PharmD, PhD
Evolving Role of Pain Physicians in Identifying and Treating Opioid Use Disorder – Richard W. Rosenquist, MD
Opioid Stewardship at the Enterprise Level – Christopher J. Gilligan, MD
FDA Approved Direct to Consumer Pharmacogenomic Testing: How Do I Respond? – Jennifer Hockings, PharmD, PhD
Ketamine for Pain Medicine
Ketamine for Chronic Pain – Samuel Samuel, MD
Ketamine for Acute Pain – Sree Kolli, MD
Ketamine: Miracle Drug or Latest Fad? – Teresa Dews, MD
Contraindications to Ketamine Treatment – Samuel Samuel, MD
Non-Pain Related Applications of Ketamine – Christopher J. Gilligan, MD
Ketamine for CRPS – Jijun Xu, MD, PhD
Panel Discussion/Question and Answer
Medical Marijuana
Role of Cannabinoids in Chronic Pain Treatment – Mark S. Wallace, MD
Adverse Effects of Cannabinoids – Scott Petersen, PA-C
Oils, Edibles, Smoking, and Vaping: How Do You Decide? – Mark S. Wallace, MD
Headaches
Evaluating the Headache Patient: When is Imaging Indicated? – Imanuel R. Lerman, MD
Rational Approach to Pharmacological Migraine Treatment – MaryAnn Mays, MD
Interventional Approaches to Headache Management – Samuel Samuel, MD
Adverse Effects of Pharmacological Treatments – MaryAnn Mays, MD
Panel Discussion/Question and Answe
